title: Myocardial perfusion after transcutaneous/percutaneous myocardial laser revascularization.
abstract: The effectiveness of transcutaneous and percutaneous myocardial laser revascularization in patients with endstage coronary artery disease and angina refractory to pharmacological therapy has been proved by various studies. Angiogenesis associated with an improvement of microcirculation and myocardial perfusion may be responsible for the reduction of angina and the improved physical performance. Myocardial perfusion studies published so far are compared to our own results utilizing positron emission tomography before and after percutaneous myocardial laser revascularization.
authors.affiliation: Kardiologische Klinik Herz- und Diabeteszentrum Georgstr. 11 32545 Bad Oeynhausen, Germany. mwiemer@hdz.nrw.de
authors.forename: Marcus
authors.initials: M
authors.lastname: Wiemer
authors.forename: Peter
authors.initials: P
authors.lastname: Wielepp
authors.forename: Thomas
authors.initials: T
authors.lastname: Butz
authors.forename: Dieter
authors.initials: D
authors.lastname: Horstkotte
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Burchert
mesh_terms: D000641:Ammonia; D000787:Angina Pectoris / Q000601:surgery; D017023:Coronary Angiography; D003326:Coronary Circulation; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000601:surgery*; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D015425:Myocardial Reperfusion; D009204:Myocardial Revascularization / Q000379:methods; D019275:Radiopharmaceuticals; D013997:Time Factors; D014055:Tomography, Emission-Computed; D014655:Vascular Resistance
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000641:Ammonia